Novel Therapeutics for Neonatal Seizures

Julie M. Ziobro, Krista Eschbach, Renée A. Shellhaas

Research output: Contribution to journalReview articlepeer-review

3 Scopus citations


Neonatal seizures are a common neurologic emergency for which therapies have not significantly changed in decades. Improvements in diagnosis and pathophysiologic understanding of the distinct features of acute symptomatic seizures and neonatal-onset epilepsies present exceptional opportunities for development of precision therapies with potential to improve outcomes. Herein, we discuss the pathophysiology of neonatal seizures and review the evidence for currently available treatment. We present emerging therapies in clinical and preclinical development for the treatment of acute symptomatic neonatal seizures. Lastly, we discuss the role of precision therapies for genetic neonatal-onset epilepsies and address barriers and goals for developing new therapies for clinical care.

Original languageEnglish
Pages (from-to)1564-1581
Number of pages18
Issue number3
StatePublished - Jul 2021


  • Antiseizure medication
  • Bumetanide
  • Hypoxic-ischemic encephalopathy
  • KCNQ2
  • Levetiracetam
  • Phenobarbital


Dive into the research topics of 'Novel Therapeutics for Neonatal Seizures'. Together they form a unique fingerprint.

Cite this